Do we need new quality markers for chronic heart failure?
Guidelines are not cookbook medicine. Medical decisions for the treatment of chronic heart failure (CHF) are more determined by patient's characteristics than by knowledge of physicians or drug patterns. New quality markers are more favourable, because they have qualitative attributes (are more flexible and adaptable for each CHF patient due to considering objective reasons for deviation from guidelines) (Ref. 44).